drugset / Trial / NCT02446301
A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers
Non-randomizedCrossoverOpen-labelTreatment
Summary
This study is to evaluate the relative bioavailability of nalbuphine after single IM injection of Sebacoyl Dinalbuphine Ester (SDE) injection and Bain®, Nalbuphine HCl IM injection in healthy volunteers.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinalbuphine sebacate | Small molecule | 150 mg | Intramuscular |
| Subject | Nalbuphine | Small molecule | 20 mg | Intramuscular |